Lanzamiento Enero 2027

Ensayo controlado aleatorizado2023Financiado por la industriaAcceso abierto

Financiado en parte por Almond Board of California

The effects of long-term almond consumption on whole-body insulin sensitivity, postprandial glucose responses, and 48 h continuous glucose concentrations in males and females with prediabetes: a randomized controlled trial

Gravesteijn E, Mensink RP, Plat J

European journal of nutrition · 10 citas

Etiquetas de revisión

Financiado por la industria

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
No se indica

Quién lo pagó

Financiación
Financiado por la industria
Grupo de la industria
Almond Board of California

Según 1 financiador declarado y la declaración de financiación del texto completo.

Publicación

Publicado
2023-05-31 · Eur J Nutr · vol. 62 · número 6 · págs. 2661–2672
Editorial
Springer Science+Business Media
Citado
15 citas · más que el 87% de estudios similares · 2.2× el promedio de su campo
Referencias
43 trabajos
Acceso
Acceso abierto (revista híbrida) · CC-BY
Áreas de investigación
Nuts composition and effects · Diet, Metabolism, and Disease · Diabetes, Cardiovascular Risks, and Lipoproteins
Palabras clave
almond consumption, prediabetes, insulin sensitivity, postprandial blood glucose, continuous glucose monitoring, hyperinsulinemic-euglycemic clamp, overweight and obesity, weight gain, energy intake, type 2 diabetes prevention, nuts, sex differences
MeSH
humans, diabetes mellitus, type 2, prediabetic state, insulin resistance, insulin, glucose, blood glucose, cross-over studies, postprandial period, female, male, prunus dulcis

3 autores

  • Elske Gravesteijn🇳🇱Maastricht University Medical Centre; Maastricht University
  • Ronald P. Mensink🇳🇱Maastricht University Medical Centre; Maastricht University
  • Jogchum Plat🇳🇱 · autor de correspondenciaMaastricht University Medical Centre; Maastricht University

Resumen

El texto original del estudio, en el idioma en que se publicó.

Purpose

Findings concerning the effects of almond consumption on glucose metabolism are inconsistent which might relate to body weight gain. The effects of long-term almond consumption on glucose metabolism are investigated in a free-living setting without detailed dietary instructions in males and females with overweight/obesity and prediabetes.

Methods

Forty-three participants volunteered in this randomized, cross-over trial with a 5-months control and intervention period and a 2-months wash-out. In the intervention period participants daily consumed 50 g whole almonds. At the end of both periods insulin sensitivity was assessed by a hyperinsulinemic euglycemic clamp, and postprandial glucose responses, and 48 h continuous glucose concentrations were measured.

Results

Almond consumption significantly decreased insulin sensitivity (P = 0.002), and increased postprandial glucose concentrations (P = 0.019), as well as fasting insulin concentrations (P = 0.003) as compared to the control period. The AUCs for 24 h glucose concentrations were not significantly different between control and intervention (P = 0.066). Almond consumption also significantly increased BMI (P = 0.002), and waist circumference (P = 0.013), supported by the concurrent increased energy intake (P = 0.031). The effects on glucose metabolism could only partly be explained by the observed weight gain as the almond effect remained after correcting for BMI changes.

Conclusions

In participants with prediabetes, long-term almond consumption showed adverse effects on insulin sensitivity and glucose metabolism. As almonds seemed not to have fully replaced other food items, it might be necessary to provide more supporting guidelines on how to incorporate energy-dense nuts into healthy diets to prevent type 2 diabetes development.

Clinical trial registration

This clinical trial was registered in February 2018 as NCT03419702.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.